Wayne Koff

6 Patents

• US124102432025

  Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies

  Theraclone Sciences Inc.

  0 cites
• US123123962025

  Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity

  The Scripps Research Institute.

  0 cites
• USRE0502682025

  Broadly Neutralizing Antibody and Uses Thereof

  Cornell University

  0 cites
• US120180672024

  Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity

  Theraclone Sciences, Inc.

  0 cites
• US118457892023

  Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies

  INTERNATIONAL AIDS VACCINE INITIATIVE, Inc.

  0 cites
• US115847892023

  Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity

  THERACLONE SCIENCES, Inc.

  0 cites